Literature DB >> 22886564

The evidence-based epidemiology of HCV-associated kidney disease.

Fabrizio Fabrizi1, Vivek Dixit, Paul Martin, Piergiorgio Messa.   

Abstract

Novel information supports a definite link between hepatitis C virus (HCV) infection and chronic kidney disease (CKD) in the general population. HCV is associated with a large spectrum of histopathological lesions in both native and transplanted kidneys. Kidney disease is probably uncommon in HCV-infected patients even if its exact frequency remains unknown. The most common HCV-associated nephropathy is type I membranoproliferative glomerulonephritis, usually in the context of type II mixed cryoglobulinemia. Controversial information exists on the relationship between positive HCV serology and CKD but several surveys at population-based level suggest that infection with HCV per se is associated with an increased risk of having or developing renal insufficiency or proteinuria. According to a novel meta-analysis of observational studies (4 clinical studies, 93,919 unique individuals), positive HCV serology was an independent and significant risk factor for proteinuria; the summary estimate for adjusted relative risk is 1.55 with a 95% confidence interval (CI) of 1.14; 2.12, p = 0.0001 (random-effects model). The mechanisms of these associations appear complex, but both viral and non-viral processes have been implicated. Prospective studies are needed to fully characterize the exact impact of chronic HCV infection on kidney function trajectories over time.

Entities:  

Mesh:

Year:  2012        PMID: 22886564     DOI: 10.5301/IJAO.2012.9448

Source DB:  PubMed          Journal:  Int J Artif Organs        ISSN: 0391-3988            Impact factor:   1.595


  5 in total

1.  High rate of acute kidney injury in patients with chronic kidney disease and hepatitis C virus genotype 4 treated with direct-acting antiviral agents.

Authors:  Ahmed Yahia Elmowafy; Hanzada Mohamed El Maghrabi; Mohamed Elsayed Mashaly; Khaled Farouk Eldahshan; Lionel Rostaing; Mohamed Adel Bakr
Journal:  Int Urol Nephrol       Date:  2019-10-14       Impact factor: 2.370

2.  Metabolic Dysregulation in Hepacivirus Infection of Common Marmosets (Callithrix jacchus).

Authors:  Cordelia Manickam; Lynn Wachtman; Amanda J Martinot; Luis D Giavedoni; R Keith Reeves
Journal:  PLoS One       Date:  2017-01-13       Impact factor: 3.240

Review 3.  Opportunities for treatment of the hepatitis C virus-infected patient with chronic kidney disease.

Authors:  Marco Ladino; Fernando Pedraza; David Roth
Journal:  World J Hepatol       Date:  2017-07-08

4.  APASL clinical practice recommendation: how to treat HCV-infected patients with renal impairment?

Authors:  Tatsuo Kanda; George K K Lau; Lai Wei; Mitsuhiko Moriyama; Ming-Lung Yu; Wang-Long Chuang; Alaaeldin Ibrahim; Cosmas Rinaldi Adithya Lesmana; Jose Sollano; Manoj Kumar; Ankur Jindal; Barjesh Chander Sharma; Saeed S Hamid; A Kadir Dokmeci; Geofferey W McCaughan; Jafri Wasim; Darrell H G Crawford; Jia-Horng Kao; Osamu Yokosuka; Shiv Kumar Sarin; Masao Omata
Journal:  Hepatol Int       Date:  2018-12-11       Impact factor: 6.047

Review 5.  Hepatitis C in Special Patient Cohorts: New Opportunities in Decompensated Liver Cirrhosis, End-Stage Renal Disease and Transplant Medicine.

Authors:  Anna Hüsing; Iyad Kabar; Hartmut H Schmidt; Hauke S Heinzow
Journal:  Int J Mol Sci       Date:  2015-08-05       Impact factor: 5.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.